Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.
In the latest session, Verrica Pharmaceuticals Inc (NASDAQ: VRCA) closed at $0.48 down -8.70% from its previous closing price of $0.52. In other words, the price has decreased by -$8.70 from its previous closing price. On the day, 0.66 million shares were traded. VRCA stock price reached its highest trading level at $0.548 during the session, while it also had its lowest trading level at $0.4625.
Ratios:
For a deeper understanding of Verrica Pharmaceuticals Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.68 and its Current Ratio is at 1.76.
Needham Upgraded its Hold to Buy on July 25, 2023, while the target price for the stock was maintained at $10.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Mar 17 ’25 when Hayes Christopher G. sold 4,315 shares for $0.65 per share. The transaction valued at 2,805 led to the insider holds 176,458 shares of the business.
Hayes Christopher G. sold 26,183 shares of VRCA for $69,647 on Aug 26 ’24. The CHIEF LEGAL OFFICER now owns 115,303 shares after completing the transaction at $2.66 per share. On Aug 27 ’24, another insider, Hayes Christopher G., who serves as the CHIEF LEGAL OFFICER of the company, sold 9,530 shares for $2.46 each. As a result, the insider received 23,444 and left with 105,773 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, VRCA now has a Market Capitalization of 47918360 and an Enterprise Value of 43361524. For the stock, the TTM Price-to-Sale (P/S) ratio is 5.78. Its current Enterprise Value per Revenue stands at 5.731 whereas that against EBITDA is -0.677.
Stock Price History:
The Beta on a monthly basis for VRCA is 1.62, which has changed by -0.9155752 over the last 52 weeks, in comparison to a change of 0.10063088 over the same period for the S&P500. Over the past 52 weeks, VRCA has reached a high of $11.41, while it has fallen to a 52-week low of $0.50. The 50-Day Moving Average of the stock is -27.47%, while the 200-Day Moving Average is calculated to be -81.73%.
Shares Statistics:
For the past three months, VRCA has traded an average of 428.58K shares per day and 709500 over the past ten days. A total of 91.78M shares are outstanding, with a floating share count of 49.69M. Insiders hold about 45.85% of the company’s shares, while institutions hold 32.67% stake in the company. Shares short for VRCA as of 1740700800 were 2032368 with a Short Ratio of 4.74, compared to 1738281600 on 2015811. Therefore, it implies a Short% of Shares Outstanding of 2032368 and a Short% of Float of 3.04.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
